Abstract
Background: Alzheimer’s disease (AD) is one of the most devastating diseases worldwide. The current drugs for AD can only ameliorate the symptoms rather than reverse or prevent the progress of AD. On the other hand, blood-brain barrier (BBB), as a natural barrier, significantly impedes drug delivery from the blood circulation into the brain. Nanomedicine can be a safe, effective and promising approach to treat AD.
Objective: This review summarizes the recent nanomedicine research in this area, including the use of liposomes and nanoparticles (NPs), to provide new approach for targeted treatment of AD.
Method: Collecting and referring to the related literature in recent 10 years, via searching MeSH Terms “Alzheimer's disease; nanomedicine; nanoparticle; amyloid β peptide; tau protein; autophagy”.
Results: Nanomedicines show superiority over conventional anti-AD drugs as a potential weapon against AD by the five proposed mechanisms: many unfavorable pharmaceutical properties of conventional anti-AD drugs maybe greatly overcome by nanomedicine; nanomedicines trigger efficient production of high-titer anti-Aβ antibodies following controlled release of antigens by them; some apolipoprotein- based nanomedicines could preferably bind to Aβ and increase the elimination of Aβ; nanomedicine-induced autophagy could be facilitated to increase the elimination of Aβ; nanomedicineinduced inhibition of tau aggregation.
Conclusion: Therefore, nanomedicine-mediated drug therapy is promising in the treatment of AD.
Keywords: Alzheimer`s disease, nanomedicine, nanoparticle, amyloid β peptide, tau protein, BBB.
Mini-Reviews in Medicinal Chemistry
Title:Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease
Volume: 18 Issue: 12
Author(s): Tian-Jun Ma , Jie Gao, Yan Liu, Jian-Hua Zhuang, Chuan Yin, Peng Li, Lei Mao, Jin Xu , Yi-Xin Xu, Yan-Peng Li , Zhong-Xin Zhao and You Yin*
Affiliation:
- Department of Neurology, Changzheng Hospital, Second Military Medical University, Shanghai 200003,China
Keywords: Alzheimer`s disease, nanomedicine, nanoparticle, amyloid β peptide, tau protein, BBB.
Abstract: Background: Alzheimer’s disease (AD) is one of the most devastating diseases worldwide. The current drugs for AD can only ameliorate the symptoms rather than reverse or prevent the progress of AD. On the other hand, blood-brain barrier (BBB), as a natural barrier, significantly impedes drug delivery from the blood circulation into the brain. Nanomedicine can be a safe, effective and promising approach to treat AD.
Objective: This review summarizes the recent nanomedicine research in this area, including the use of liposomes and nanoparticles (NPs), to provide new approach for targeted treatment of AD.
Method: Collecting and referring to the related literature in recent 10 years, via searching MeSH Terms “Alzheimer's disease; nanomedicine; nanoparticle; amyloid β peptide; tau protein; autophagy”.
Results: Nanomedicines show superiority over conventional anti-AD drugs as a potential weapon against AD by the five proposed mechanisms: many unfavorable pharmaceutical properties of conventional anti-AD drugs maybe greatly overcome by nanomedicine; nanomedicines trigger efficient production of high-titer anti-Aβ antibodies following controlled release of antigens by them; some apolipoprotein- based nanomedicines could preferably bind to Aβ and increase the elimination of Aβ; nanomedicine-induced autophagy could be facilitated to increase the elimination of Aβ; nanomedicineinduced inhibition of tau aggregation.
Conclusion: Therefore, nanomedicine-mediated drug therapy is promising in the treatment of AD.
Export Options
About this article
Cite this article as:
Ma Tian-Jun , Gao Jie , Liu Yan, Zhuang Jian-Hua, Yin Chuan , Li Peng , Mao Lei , Xu Jin , Xu Yi-Xin, Li Yan-Peng , Zhao Zhong-Xin and Yin You *, Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease, Mini-Reviews in Medicinal Chemistry 2018; 18 (12) . https://dx.doi.org/10.2174/1389557518666171215150024
DOI https://dx.doi.org/10.2174/1389557518666171215150024 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences
Current Gene Therapy Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer
Anti-Cancer Agents in Medicinal Chemistry The Cytotoxic and Mechanistic Effects of Aaptamine on Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Interrelation of Major Depression and Antidepressant Transcriptomics
Current Psychopharmacology Development of <sup>18</sup>F-Labeled PET Probes for Imaging Cell Proliferation
Current Topics in Medicinal Chemistry Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets Vagotomy and Gastric Tumorigenesis
Current Neuropharmacology The Targets of Curcumin
Current Drug Targets Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery Anti-Angiogenic Therapies for Children with Cancer
Current Cancer Drug Targets Oncologic Imaging End-Points for the Assessment of Therapy Response
Recent Patents on Anti-Cancer Drug Discovery Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design Roles of p75NTR in Maintaining Brain Hemostasis and the Implications for p75NTR-targeted Therapies
Current Alzheimer Research Current and Future Drug Treatments for Glioblastomas
Current Medicinal Chemistry Comparison of Anticancer Properties of Annona muricata L. Acetonic and Methanolic Leaf Extracts
The Natural Products Journal A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs
Drug Metabolism Letters Triterpenoids for Cancer Prevention and Treatment: Current Status and Future Prospects
Current Pharmaceutical Biotechnology Non Polymeric Nanoparticles for Photodynamic Therapy Applications: Recent Developments
Current Medicinal Chemistry Cancer Pharmacogenetics: The Move from Pharmacokinetics to Pharmacodynamics
Current Pharmacogenomics